Evidence map›Paper›PMID 24349139›Full record

ArticlePloS one2013

Deciphering the complex distribution of human immunodeficiency virus type 1 subtypes among different cohorts in Northern Tanzania.

Harr F Njai, Fiona M Ewings, Eric Lyimo, Vincent Foulongne, Dhamira Ngerageza, Aika Mongi, Deogratius Ssemwanga, Aura Andreasen, Balthazar Nyombi, Tony Ao and 7 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Observational
  2. Observational
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 4 countries.

Harr F NjaiMwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania ; London School of Hygiene and Tropical Medicine, London, United Kingdom.
Fiona M EwingsMwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania ; MRC Tropical Epidemiology Group, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Eric LyimoNational Institute for Medical Research, Mwanza, Tanzania.
Vincent FoulongneLaboratoire de Virologie, University of Montpellier, Montpellier, France.
Dhamira NgeragezaNational Institute for Medical Research, Mwanza, Tanzania.
Aika MongiMwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania.
Deogratius SsemwangaMRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.
Aura AndreasenMwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania ; London School of Hygiene and Tropical Medicine, London, United Kingdom.
Balthazar NyombiKilimanjaro Christian Medical Centre, Moshi, Tanzania.
Tony AoMwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania ; London School of Hygiene and Tropical Medicine, London, United Kingdom.
Denna MichaelNational Institute for Medical Research, Mwanza, Tanzania.
Mark UrassaNational Institute for Medical Research, Mwanza, Tanzania.
Jim ToddLondon School of Hygiene and Tropical Medicine, London, United Kingdom ; National Institute for Medical Research, Mwanza, Tanzania ; Kilimanjaro Christian Medical Centre, Moshi, Tanzania.
Basia ZabaLondon School of Hygiene and Tropical Medicine, London, United Kingdom.
John ChangaluchaNational Institute for Medical Research, Mwanza, Tanzania.
Richard HayesMRC Tropical Epidemiology Group, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Saidi H KapigaMwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania ; London School of Hygiene and Tropical Medicine, London, United Kingdom.
National Institute for Medical Research · TZLondon School of Hygiene & Tropical Medicine · GBMwanza Intervention Trials Unit · TZKilimanjaro Christian Medical Centre · TZUganda Virus Research Institute · UGUniversité de Montpellier · FR

Funding

Medical Research Council G0901756Medical Research Council MR/K012126/1
6 · The paper itself

Abstract

backgroundIncreased understanding of the genetic diversity of HIV-1 is challenging but important in the development of an effective vaccine. We aimed to describe the distribution of HIV-1 subtypes in northern Tanzania among women enrolled in studies preparing for HIV-1 prevention trials (hospitality facility-worker cohorts), and among men and women in an open cohort demographic surveillance system (Kisesa cohort).

methodsThe polymerase encompassing partial reverse transcriptase was sequenced and phylogenetic analysis performed and subtype determined. Questionnaires documented demographic data. We examined factors associated with subtype using multinomial logistic regression, adjusted for study, age, and sex.

resultsAmong 140 individuals (125 women and 15 men), subtype A1 predominated (54, 39%), followed by C (46, 33%), D (25, 18%) and unique recombinant forms (URFs) (15, 11%). There was weak evidence to suggest different subtype frequencies by study (for example, 18% URFs in the Kisesa cohort versus 5-9% in the hospitality facility-worker cohorts; adjusted relative-risk ratio (aRR) = 2.35 [95% CI 0.59,9.32]; global p = 0.09). Compared to men, women were less likely to have subtype D versus A (aRR = 0.12 [95% CI 0.02,0.76]; global p = 0.05). There was a trend to suggest lower relative risk of subtype D compared to A with older age (aRR = 0.44 [95% CI 0.23,0.85] per 10 years; global p = 0.05).

conclusionsWe observed multiple subtypes, confirming the complex genetic diversity of HIV-1 strains circulating in northern Tanzania, and found some differences between cohorts and by age and sex. This has important implications for vaccine design and development, providing opportunity to determine vaccine efficacy in diverse HIV-1 strains.

Indexed as

GenotypePhylogenyAdultFemaleGenetic VariationHigh-Throughput Nucleotide SequencingHIV-1HIV InfectionsHIV Reverse TranscriptaseHumansLogistic ModelsMaleMiddle AgedMolecular TypingTanzaniaHIV Reverse Transcriptase

Identifiers

PMID24349139
PMCPMC3859540
OpenAlexW2018019982

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.